Lorenzo Legramandi
Overview
Explore the profile of Lorenzo Legramandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
89
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurizzan C, Cinquini M, Legramandi L, Resteghini C, Siano M, Bergamini C, et al.
Ther Adv Med Oncol
. 2025 Jan;
17():17588359241288251.
PMID: 39801611
Objectives: A combination of chemotherapy and radiotherapy is employed in the curative and postoperative treatment of locally advanced head and neck cancers (HNC). Integrated chemoradiation (CRT) treatments result in a...
2.
La Verde N, Damia G, Garrone O, Santini D, Fabi A, Ciccarese M, et al.
Breast Cancer Res
. 2022 Oct;
24(1):71.
PMID: 36307826
Background: Metastatic breast cancer (MBC) is an incurable disease and its treatment focuses on prolonging patients' (pts) overall survival (OS) and improving their quality of life. Eribulin is a microtubule...
3.
Galli G, Corsetto P, Proto C, Lo Russo G, Ganzinelli M, Rulli E, et al.
Clin Lung Cancer
. 2022 Aug;
23(7):e489-e499.
PMID: 35948460
Introduction: Lipid metabolism impacts immune cell differentiation, activation, and functions, modulating inflammatory mediators, energy homeostasis, and cell membrane composition. Despite preclinical evidence, data in humans lack concerning tumors and immunotherapy...
4.
Riva I, Legramandi L, Rulli E, Konstas A, Katsanos A, Oddone F, et al.
Sci Rep
. 2020 Mar;
10(1):4517.
PMID: 32144291
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
5.
Cirillo M, Carlucci L, Legramandi L, Baldini E, Sacco C, Zagonel V, et al.
J Clin Nurs
. 2019 Sep;
29(1-2):119-129.
PMID: 31532035
Aims And Objectives: To assess the effectiveness of a specific home care nursing programme in addition to standard care in patients (pts) receiving oral anticancer treatments. Background: Oral anticancer therapy...
6.
Quaranta L, Riva I, Biagioli E, Rulli E, Rulli E, Poli D, et al.
Adv Ther
. 2019 Jul;
36(9):2506-2514.
PMID: 31301054
Introduction: The CoQun study is a multicenter, controlled trial aimed to evaluate the neuroprotective effects of Coqun, an ophthalmic solution of Coenzyme q10 (CoQ10) and Vitamin E (VitE), in patients...
7.
Rulli E, Legramandi L, Salvati L, Mandala M
Cancer
. 2019 Jul;
125(21):3776-3789.
PMID: 31287564
Background: Targeted therapies (TT), combination immunotherapy (CMI), and monoimmunotherapy (MI) in combination with radiotherapy (CRI) or not are commonly used in patients with melanoma brain metastases, but studies that directly...
8.
Riva I, Legramandi L, Rulli E, Konstas A, Katsanos A, Oddone F, et al.
Sci Rep
. 2019 May;
9(1):6735.
PMID: 31043703
To evaluate the change over time of vision-related quality of life (QoL) and glaucoma symptoms in a population of newly-diagnosed primary open angle glaucoma (POAG) patients. Multicenter, prospective study. Consecutive...
9.
Corli O, Iorno V, Legramandi L, Rulli E, Roberto A, Azzarello G, et al.
Pain Pract
. 2019 Mar;
PMID: 30917409
Background: Oxycodone-Naloxone (OXN) aims to reduce opioid-related constipation while being successfully analgesic. Methods: We evaluated the analgesic response, prevalence, and severity of side effects in 176 cancer patients with moderate...
10.
Riva I, Legramandi L, Katsanos A, Oddone F, Rulli E, Roberti G, et al.
J Glaucoma
. 2018 May;
27(9):776-784.
PMID: 29781833
Purpose: The purpose of this article was to evaluate the potential association between sociodemographic factors with clinical characteristics, vision-related quality of life (QoL), and glaucoma-related symptoms scores in a large...